Normal Healthy Volunteers Clinical Trial
Official title:
Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display
This prospective study investigated the validity and test-retest reliability of stereopsis test using head-mount display (HMD). Contour-based circles (crossed disparity: 1,960 to 195 arc of seconds(arc secs)) were generated as separate images on a high resolution phone display (Galaxy S7; Samsung, Suwon, Korea) using a HMD (Galaxy Gear VR; Samsung, Suwon, Korea). Two images were independently projected to each eye as graded circles with random dot background. While the position of the stimulus changed from among 3 possible locations, the subjects were instructed to select the circle with disparity by pressing the corresponding position on a keypad. The results of the new HMD stereotest were compared to those from standard Randot and TNO stereotests.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05019950 -
Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers
|
Phase 1 | |
Completed |
NCT01366339 -
Tolerance and Pharmacokinetics Study of MNTX Tablets
|
Phase 1 | |
Completed |
NCT01862835 -
Impact of Estradiol Addback
|
Phase 1 | |
Completed |
NCT01629446 -
Lofexidine Mass Balance in Volunteers
|
Phase 1 | |
Completed |
NCT02026973 -
Impact of Endogenous E2 on SSI and GH Rebound
|
Phase 1 | |
Completed |
NCT03860571 -
Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
|
Phase 1 | |
Completed |
NCT04188730 -
A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution
|
Phase 1 | |
Completed |
NCT02271282 -
Estradiol-Receptor Blockade in Older Men and Women
|
Phase 1 | |
Withdrawn |
NCT03291158 -
Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV
|
Phase 1 | |
Completed |
NCT02802631 -
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults
|
Phase 1 |